Riskpilot← Back to searchSign inGet full accessCortendo AB
ABActiveOrg 5565376554Vasagatan 38Research and experimental development on natural sciences and engineering · NACE 7210Est. 19960 employees
Revenue 2024
SEK 0
EBITDA margin
—
-47% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
SEK -592K
-370% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -600K | -47% |
| Net profit | SEK -592K | -370% |
| Total assets | SEK 470,2M | +0% |
| Equity | SEK 469,1M | +0% |
| Employees | 0 | — |
Legal name
Cortendo AB
Org number
5565376554
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
30 december 1996
Share capital
SEK 206 899 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Firman tecknas av en av ledamöterna i förening med Yelmene, Michele
Company purpose
Bolaget skall utveckla och exploatera medicinska innovationer avseende läkemedel, diagnostika och andra hjälpmedel inom sjuk- och hälsovården samt jämväl äga aktier i bolag som bedriver sådan verksamhet.
Address
Vasagatan 38
Phone
+4635125430
Email
j.englund@strongbridgebio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −228 550 | −126 468 | −138 485 | 690 939 | 26 | 0 | −1 | −523 | −409 | −600 |
| Depreciation & amort. | −0 | −0 | — | — | — | — | — | — | — | — |
| EBIT | −228 550 | −126 468 | −138 485 | 690 939 | 26 | 0 | −1 | −523 | −409 | −600 |
| Net financials | 10 977 | −119 925 | −137 302 | −40 244 | 55 | — | −826 | −3 418 | 283 | 8 |
| Profit before tax | −217 573 | −246 394 | −275 788 | 650 695 | 81 | −1 | −414 | −3 940 | −126 | −592 |
| Tax | −0 | −0 | −0 | −2 499 | −17 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −217 573 | −246 394 | −275 788 | 648 196 | 64 | −1 | −414 | −3 940 | −126 | −592 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 738 914 | 448 414 | 209 505 | 901 517 | 882 | 889 | 470 | 469 951 | 470 042 | 470 188 |
| Equity | 694 419 | 448 062 | 149 591 | 797 787 | 862 | 861 | 447 | 443 045 | 469 732 | 469 140 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 44 495 | 352 | 59 914 | 103 730 | 20 | 27 | 23 | 26 906 | 310 | 1 048 |
| Total debt | 44 495 | 352 | 59 914 | 103 730 | 20 | 27 | 23 | 26 906 | 310 | 1 048 |
EBITDA margin
-60000000.0%
This company
15.8%
Market median
-379746935% vs market
20152024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20152024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20152024
Net profit margin
-59200000.0%
This company
8.1%
Market median
-730864298% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
CF Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
FJ External Signatory | External Signatory | 2020 | — | — |
NE Chief Auditor | Chief Auditor | 2020 | — | — |
AM Chief Auditor | Chief Auditor | 2025 | — | — |
MY External Signatory | External Signatory | 2020 | — | — |
MT Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
STRONGBRIDGE BIOPHARMA LTD | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
STRONGBRIDGE BIOPHARMA LTD
Cortendo AB (this company)Board members of Cortendo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Matthew Rudolph Pauls | Chief Executive Officer | 0 companies |
| Kevin Michael Butler | Chief Executive Officer | 0 companies |
| Carl Fredrik Wilhelm Mörner | Authorized Recipient of Service | 0 companies |
| Fredric Jay Cohen | External Signatory | 0 companies |
| Nina Elisabeth Bergman | Chief Auditor | 0 companies |
| Alexandra Metta Funseth | Chief Auditor | 0 companies |
| Michele Yelmene | External Signatory | 0 companies |
| Mikael Thomas Gunnar Edman | Chief Auditor | 0 companies |
| Richard Scott Kollender | Chairman | 0 companies |
| Louise Barrett | Board of Directors | 0 companies |
| Robert Matthew Lutz | Chairman | 0 companies |
| Stephen James Healy | Deputy Board Member | 0 companies |
| Steven Michael Pieper | Deputy Board Member | 0 companies |
| Stephen John Long | Board of Directors | 0 companies |
| John Martin Hackett | Board of Directors | 0 companies |
| Beth P Hecht | Chairman | 0 companies |